Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free MIST Stock Alerts

Milestone Pharmaceuticals (MIST) Earnings Date, Estimates & Call Transcripts

Milestone Pharmaceuticals logo
$1.72 -0.18 (-9.47%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$1.66 -0.06 (-3.43%)
As of 09:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Milestone Pharmaceuticals Earnings Summary

Milestone Pharmaceuticals issued Q1 2026 earnings on May 13, 2026, reporting an EPS of -$0.20, which missed the consensus estimate of -$0.03 by $0.17. Quarterly revenue was reported to be $0.24 million, below analysts' expectations of $30.12 million. With a trailing EPS of -$0.79, Milestone Pharmaceuticals' earnings are expected to decrease next year, from ($0.47) to ($0.91) per share.

Latest Q1
Earnings Date
May. 13Estimated
Consensus EPS
(May. 13)
-$0.03
Actual EPS
(May. 13)
-$0.20 Missed By -$0.17
Actual Revenue
(May. 13)
$0.24M

Q1 2026 Earnings Resources

Powered by Quartr
Get Milestone Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Milestone Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

MIST Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MIST Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Milestone Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.23-$0.23-$0.23
Q2 20262-$0.20-$0.20-$0.20
Q3 20261-$0.22-$0.22-$0.22
Q4 20261-$0.20-$0.20-$0.20

Milestone Pharmaceuticals Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/13/2026Q1 2026-$0.03-$0.20 -$0.17-$0.20$30.12M$0.24M
3/20/2026Q4 2025-$0.18-$0.16+$0.02-$0.15$37.52M$1.55M
11/12/2025Q3 2025-$0.17-$0.12+$0.05-$0.12--
8/12/2025Q2 2025-$0.18-$0.20 -$0.02-$0.20--
5/14/2025Q1 2025-$0.19-$0.31 -$0.12-$0.31--
11/12/2024--$0.18-$0.14+$0.04-$0.14--
8/8/2024--$0.19-$0.14+$0.05-$0.14--

Data powered by Fiscal.ai.

Milestone Pharmaceuticals Earnings - Frequently Asked Questions

Milestone Pharmaceuticals (NASDAQ:MIST) last announced its quarterly earning data on Wednesday, May 13, 2026. Learn more on MIST's earnings history.

In the previous quarter, Milestone Pharmaceuticals (NASDAQ:MIST) missed the analysts' consensus estimate of ($0.03) by $0.17 with a reported earnings per share (EPS) of ($0.20). Learn more on analysts' earnings estimate vs. MIST's actual earnings.

The conference call for Milestone Pharmaceuticals' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Milestone Pharmaceuticals' latest earnings report can be read online.
Read Transcript

Milestone Pharmaceuticals (NASDAQ:MIST) has a recorded annual revenue of $1.55 million.

Milestone Pharmaceuticals (NASDAQ:MIST) has a recorded net income of -$63.06 million. MIST has generated -$0.79 earnings per share over the last four quarters.

Milestone Pharmaceuticals' earnings are expected to decrease from ($0.47) per share to ($0.91) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:MIST) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
The US sanctioned itself out of world reserve status…
Russia and Iran are both bypassing the US petrodollar - settling oil trades in alternative currencies while ce...
Golden Portfolio | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
Secret behind near perfectly timed stock trades…?
After 20 years of professional trading, Ross Givens says this is the single most lucrative market strategy he ...
Traders Agency | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel